Clinical Trials Browser

Completed × Carcinoma, Hepatocellular × apatinib × Clear all

NCT02329860 2024-01-22

Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)

Phase 3 Completed

400 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular